| Long non-coding RNAs: functional regulatory players in breast cancer RA Youness, MZ Gad Non-coding RNA research 4 (1), 36-44, 2019 | 94 | 2019 |
| The long noncoding RNA sONE represses triple‐negative breast cancer aggressiveness through inducing the expression of miR‐34a, miR‐15a, miR‐16, and let‐7a RA Youness, HM Hafez, E Khallaf, RA Assal, A Abdel Motaal, MZ Gad Journal of Cellular Physiology 234 (11), 20286-20297, 2019 | 86 | 2019 |
| MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc RA Youness, HM El-Tayebi, RA Assal, K Hosny, G Esmat, AI Abdelaziz Oncology Letters 12 (4), 2567-2573, 2016 | 81 | 2016 |
| Recent advances in tannic acid (gallotannin) anticancer activities and drug delivery systems for efficacy improvement; a comprehensive review R A. Youness, R Kamel, N A. Elkasabgy, P Shao, M A. Farag Molecules 26 (5), 1486, 2021 | 80 | 2021 |
| MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions AM ElKhouly, RA Youness, MZ Gad Non-coding RNA research 5 (1), 11-21, 2020 | 69 | 2020 |
| Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular carcinoma YM Shaalan, H Handoussa, RA Youness, RA Assal, AH El-Khatib, ... Natural Product Research 32 (18), 2217-2220, 2018 | 57 | 2018 |
| Targeting hydrogen sulphide signaling in breast cancer RA Youness, AZ Gad, K Sanber, YJ Ahn, GJ Lee, E Khallaf, HM Hafez, ... Journal of advanced research 27, 177-190, 2021 | 54 | 2021 |
| A methoxylated quercetin glycoside harnesses HCC tumor progression in a TP53/miR-15/miR-16 dependent manner R Ahmed Youness, R Amr Assal, S Mohamed Ezzat, M Zakaria Gad, ... Natural Product Research 34 (10), 1475-1480, 2020 | 49 | 2020 |
| A novel role of sONE/NOS3/NO signaling cascade in mediating hydrogen sulphide bilateral effects on triple negative breast cancer progression RA Youness, RA Assal, AA Motaal, MZ Gad Nitric oxide 80, 12-23, 2018 | 49 | 2018 |
| Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor … RA Youness, MA Rahmoon, RA Assal, AI Gomaa, MT Hamza, I Waked, ... Growth Factors 34 (3-4), 128-140, 2016 | 48 | 2016 |
| Why natural killer cells in triple negative breast cancer? M Abdel-Latif, RA Youness World Journal of Clinical Oncology 11 (7), 464, 2020 | 44 | 2020 |
| MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients MA Rahmoon, RA Youness, AI Gomaa, MT Hamza, I Waked, ... Growth Factors 35 (2-3), 76-87, 2017 | 44 | 2017 |
| LncRNA HEIH/miR‐939‐5p interplay modulates triple‐negative breast cancer progression through NOS2‐induced nitric oxide production H Nafea, RA Youness, K Abou‐Aisha, MZ Gad Journal of Cellular Physiology 236 (7), 5362-5372, 2021 | 42 | 2021 |
| Fat-soluble vitamins: updated review of their role and orchestration in human nutrition throughout life cycle with sex differences RA Youness, A Dawoud, O ElTahtawy, MA Farag Nutrition & Metabolism 19 (1), 60, 2022 | 38 | 2022 |
| MALAT-1/p53/miR-155/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer M Abdel-Latif, A Riad, RA Soliman, AM Elkhouly, H Nafae, MZ Gad, ... Molecular and Cellular Biochemistry 477 (4), 1281-1293, 2022 | 33 | 2022 |
| An acetylated derivative of vitexin halts MDA-MB-231 cellular progression and improves its immunogenic profile through tuning miR-20a-MICA/B axis AR Awad, RA Youness, M Ibrahim, AA Motaal, HI El-Askary, RA Assal, ... Natural product research 35 (18), 3126-3130, 2021 | 33 | 2021 |
| Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models RY Mekky, N El-Ekiaby, SA El Sobky, NM Elemam, RA Youness, ... Archives of virology 164, 1587-1595, 2019 | 32 | 2019 |
| Reduction of CD19 autoimmunity marker on B cells of paediatric SLE patients through repressing PU. 1/TNF-α/BAFF axis pathway by miR-155 HR Aboelenein, MT Hamza, H Marzouk, RA Youness, M Rahmoon, ... Growth Factors 35 (2-3), 49-60, 2017 | 29 | 2017 |
| MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer RY Mekky, MF Ragab, T Manie, AA Attia, RA Youness Translational Oncology 31, 101653, 2023 | 28 | 2023 |
| Hindering the synchronization between miR-486-5p and H19 lncRNA by hesperetin halts breast cancer aggressiveness through tuning ICAM-1 RM Abdallah, AM Elkhouly, RA Soliman, N El Mechawy, A El Sebaei, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 28 | 2022 |
Mohamed Zakaria GadProfessor of Biochemistry, Faculty of Pharmacy & Biotechnology, The German University in Cairo在 guc.edu.eg 的电子邮件经过验证
